Novavax Inc (NVAX)
$44.84 0.63 (1.39%)
19:59 EDT NVAX Stock Quote Delayed 30 Minutes
Previous Close $44.84
Market Cap 17.11B
PE Ratio -73.51
Volume (Avg. Vol.) 4.96M
Day's Range 44.52 - 46.60
52-Week Range 3.54 - 61.50
Dividend & Yield N/A (N/A)
NVAX Stock Predictions, Articles, and Novavax Inc News
- From InvestorPlace
- From the Web
A race to develop a coronavirus vaccine is on, and these red-hot Covid-19 vaccine stocks are leading the way.
Uber, Novavax, DraftKings and Aurora Cannabis were our top stock trades for Wednesday. Let's have a look at what the charts say.
Novavax (NVAX) news for Tuesday concerning funding for a vaccine to stop the novel coronavirus has NVAX stock rocketing higher.
Novavax (NVAX) news for Wednesday concerning a trial for a vaccine to treat the coronavirus from China has NVAX stock flying high.
Investors began buying up NVAX shares in anticipation of the Phase 3 clinical trial announcement. We wound up with a 130% gain on the trade.
Unlike the broader market, these stocks to buy have managed to hold up strong amid the ongoing public health crisis.
Wall Street pros recommend making an investment decision based on multiple factors rather than just a single metric like fundamentals.
Novavax (NVAX) earnings for the vaccine company's fiscal fourth quarter of 2019 have NVAX stock heading higher after-hours Wednesday.
Tesla made its one-millionth car, while Delta expects to save $2 billion in fuel costs. Here's the stock market today.
Boeing shares tanked on more negative reports, while Uber rallied on an asset sale. Here's what happened in the stock market today.
Novavax (NVAX) news for Tuesday concerning the spread of a virus in China has NVAX stock heading higher as more investors pick up the stock.
For investors seeking out the ultimate high-risk, high-reward stocks, look no further than the biotech industry.
Novavax news for Thursday concerning an accelerated approval pathway for one of the company's drugs has NVAX stock soaring higher.
With the major indices showing signs of hesitancy, now is an ideal time to consider lesser-known but viable cheap stocks.
Novavax stock is plunging on Thursday after failing a Phase 3 study. That sets up a breakdown instead of a breakout in NVAX stock.
The drugs/biotech sector has been down since the past month, reeling under broader market pressures. Only a few good stocks however, remain out of this rut. Com....
From Seeking Alpha
The Alerus Financial (NASDAQ:ALRS) Share Price Is Down 9.8% So Some Shareholders Are Getting Worried
In order to justify the effort of selecting individual stocks, it’s worth striving to beat the returns from a market index fund. But if you try your hand at stock<div><a class="permalink" href="https://simplywall.st/stocks/us/diversified-financials/nasdaq-alrs/alerus-financial/news/the-alerus-financial-nasdaqalrs-share-price-is-down-9-8-so-some-shareholders-are-getting-worried/">Read More...</a></div>
Dividend paying stocks like Alerus Financial Corporation (NASDAQ:ALRS) tend to be popular with investors, and for good reason – some research suggests a significant amount of all stock market returns<div><a class="permalink" href="https://simplywall.st/stocks/us/diversified-financials/nasdaq-alrs/alerus-financial/news/what-to-know-before-buying-alerus-financial-corporation-nasdaqalrs-for-its-dividend/">Read More...</a></div>
The big shareholder groups in Alerus Financial Corporation (NASDAQ:ALRS) have power over the company. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their<div><a class="permalink" href="https://simplywall.st/stocks/us/diversified-financials/nasdaq-alrs/alerus-financial/news/how-much-of-alerus-financial-corporation-nasdaqalrs-do-insiders-own/">Read More...</a></div>
Navellier RatingsPowered by Portfolio Grader